Optimizing the macrocyclic diterpenic core toward the reversal of multidrug resistance in cancer

Rafael Baptista, Ricardo J. Ferreira, Daniel Jva Dos Santos, Miguel X. Fernandes, Maria-José U. Ferreira

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

11 Dyfyniadau (Scopus)

Crynodeb

Background: From a dataset obtained by chemical derivatization of a macrocyclic diterpenic scaffold, in silico approaches identified which structural features correlate with experimental modulation of P-gp activity. 

Results/methodology: Ninety-two percent of the strongest MDR modulators were positively identified within the dataset by virtual screening. Quantitative structure-activity relationships models with high robustness and predictability were obtained for both MDR1-transfected L5178Y mouse lymphoma T-cells (q(2) 0.875, R(2) pred 0.921) and human colon adenocarcinoma (q(2) 0.820, R(2) pred 0.951) cell lines. A new pharmacophoric model suggests that charge distribution within the molecule is important for biological activity.

Conclusion: For the studied diterpenes, the conformation of the macrocyclic scaffold and its substitution pattern are the main determinants for the biological activity, being related with steric and electrostatic factors.

Iaith wreiddiolSaesneg
Tudalennau (o-i)629-645
Nifer y tudalennau17
CyfnodolynFuture Medicinal Chemistry
Cyfrol8
Rhif cyhoeddi6
Dynodwyr Gwrthrych Digidol (DOIs)
StatwsCyhoeddwyd - 22 Ebr 2016
Cyhoeddwyd yn allanolIe

Ôl bys

Gweld gwybodaeth am bynciau ymchwil 'Optimizing the macrocyclic diterpenic core toward the reversal of multidrug resistance in cancer'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

Dyfynnu hyn